Cardiovascular events according to blood pressure thresholds recommended by ACC/AHA

Research output: Contribution to journalJournal articleResearchpeer-review

Standard

Cardiovascular events according to blood pressure thresholds recommended by ACC/AHA. / Joseph, Gowsini; Thanh Pham, Vi; Kragh Andersen, Per; Louis Marott, Jacob; Møgelvang, Rasmus; Biering-Sørensen, Tor; Søgaard, Peter; Nielsen, Gitte; Prescott, Eva; Boje Jensen, Gorm; Eske Bruun, Niels; Torp-Pedersen, Christian.

In: Blood Pressure, Vol. 33, No. 1, 2380346, 2024.

Research output: Contribution to journalJournal articleResearchpeer-review

Harvard

Joseph, G, Thanh Pham, V, Kragh Andersen, P, Louis Marott, J, Møgelvang, R, Biering-Sørensen, T, Søgaard, P, Nielsen, G, Prescott, E, Boje Jensen, G, Eske Bruun, N & Torp-Pedersen, C 2024, 'Cardiovascular events according to blood pressure thresholds recommended by ACC/AHA', Blood Pressure, vol. 33, no. 1, 2380346. https://doi.org/10.1080/08037051.2024.2380346

APA

Joseph, G., Thanh Pham, V., Kragh Andersen, P., Louis Marott, J., Møgelvang, R., Biering-Sørensen, T., Søgaard, P., Nielsen, G., Prescott, E., Boje Jensen, G., Eske Bruun, N., & Torp-Pedersen, C. (2024). Cardiovascular events according to blood pressure thresholds recommended by ACC/AHA. Blood Pressure, 33(1), [2380346]. https://doi.org/10.1080/08037051.2024.2380346

Vancouver

Joseph G, Thanh Pham V, Kragh Andersen P, Louis Marott J, Møgelvang R, Biering-Sørensen T et al. Cardiovascular events according to blood pressure thresholds recommended by ACC/AHA. Blood Pressure. 2024;33(1). 2380346. https://doi.org/10.1080/08037051.2024.2380346

Author

Joseph, Gowsini ; Thanh Pham, Vi ; Kragh Andersen, Per ; Louis Marott, Jacob ; Møgelvang, Rasmus ; Biering-Sørensen, Tor ; Søgaard, Peter ; Nielsen, Gitte ; Prescott, Eva ; Boje Jensen, Gorm ; Eske Bruun, Niels ; Torp-Pedersen, Christian. / Cardiovascular events according to blood pressure thresholds recommended by ACC/AHA. In: Blood Pressure. 2024 ; Vol. 33, No. 1.

Bibtex

@article{9894c32966f444ca936a3f1b41855177,
title = "Cardiovascular events according to blood pressure thresholds recommended by ACC/AHA",
abstract = "Aim: The latest guidelines from ACC/AHA define hypertension at systolic blood pressure (SBP) 130-139 mmHg or diastolic blood pressure (DBP) 80-89 mmHg in contrast to guidelines from ESC/ESH defining hypertension at SBP ≥ 140 mmHg or DBP ≥ 90 mmHg. The aim was to determine whether the ACC/AHA definition of hypertension identifies persons at elevated risk for future cardiovascular outcome. Methods: In a Danish prospective cardiovascular study, 19,721 white men and women aged 20-98 years were examined up to five occasions between 1976 and 2015. The population was followed until December 2018. The ACC/AHA definition of the BP levels were applied: Normal: SBP <120 mmHg and DBP <80 mmHg, Elevated: SBP 120-129 mmHg and DBP <80 mmHg, Stage 1: SBP 130-139 mmHg or DBP 80-89 mmHg, Stage 2: SBP ≥140 mmHg or DBP ≥90 mmHg. Absolute 10-year risk was calculated taking repeated examinations, covariates, and competing risk into account. Results: For all outcomes, the 10-year risk in stage 1 hypertension did not differ significantly from risk in subjects with normal BP: The 10-year risk of cardiovascular events in stage 1 hypertension was 14.1% [95% CI 13.2;15.0] and did not differ significantly from the risk in normal BP at 12.8% [95% CI 11.1;14.5] (p = 0.19). The risk was highest in stage 2 hypertension 19.4% [95% CI 18.9;20.0] and differed significantly from normal BP, elevated BP, and stage 1 hypertension (p < 0.001). The 10-year risk of cardiovascular death was 6.6% [95% CI 5.9;7.4] in stage 1 hypertension and did not differ significantly from the risk in normal BP at 5.7% [95% CI 4.1;7.3] (p = 0.33). Conclusions: Stage 1 hypertension as defined by the ACC/AHA guidelines has the same risk for future cardiovascular events as normal BP. In contrast, the definition of hypertension as suggested by ESC/ESH identifies patients with elevated risk of cardiovascular events.",
keywords = "ACC/AHA guidelines, blood pressure thresholds, cardiovascular outcome, hypertension, mortality",
author = "Gowsini Joseph and {Thanh Pham}, Vi and {Kragh Andersen}, Per and {Louis Marott}, Jacob and Rasmus M{\o}gelvang and Tor Biering-S{\o}rensen and Peter S{\o}gaard and Gitte Nielsen and Eva Prescott and {Boje Jensen}, Gorm and {Eske Bruun}, Niels and Christian Torp-Pedersen",
note = "Publisher Copyright: {\textcopyright} 2024 The Author(s). Published by Informa UK Limited, trading as Taylor & Francis Group.",
year = "2024",
doi = "10.1080/08037051.2024.2380346",
language = "English",
volume = "33",
journal = "Blood Pressure",
issn = "0803-7051",
publisher = "Taylor & Francis",
number = "1",

}

RIS

TY - JOUR

T1 - Cardiovascular events according to blood pressure thresholds recommended by ACC/AHA

AU - Joseph, Gowsini

AU - Thanh Pham, Vi

AU - Kragh Andersen, Per

AU - Louis Marott, Jacob

AU - Møgelvang, Rasmus

AU - Biering-Sørensen, Tor

AU - Søgaard, Peter

AU - Nielsen, Gitte

AU - Prescott, Eva

AU - Boje Jensen, Gorm

AU - Eske Bruun, Niels

AU - Torp-Pedersen, Christian

N1 - Publisher Copyright: © 2024 The Author(s). Published by Informa UK Limited, trading as Taylor & Francis Group.

PY - 2024

Y1 - 2024

N2 - Aim: The latest guidelines from ACC/AHA define hypertension at systolic blood pressure (SBP) 130-139 mmHg or diastolic blood pressure (DBP) 80-89 mmHg in contrast to guidelines from ESC/ESH defining hypertension at SBP ≥ 140 mmHg or DBP ≥ 90 mmHg. The aim was to determine whether the ACC/AHA definition of hypertension identifies persons at elevated risk for future cardiovascular outcome. Methods: In a Danish prospective cardiovascular study, 19,721 white men and women aged 20-98 years were examined up to five occasions between 1976 and 2015. The population was followed until December 2018. The ACC/AHA definition of the BP levels were applied: Normal: SBP <120 mmHg and DBP <80 mmHg, Elevated: SBP 120-129 mmHg and DBP <80 mmHg, Stage 1: SBP 130-139 mmHg or DBP 80-89 mmHg, Stage 2: SBP ≥140 mmHg or DBP ≥90 mmHg. Absolute 10-year risk was calculated taking repeated examinations, covariates, and competing risk into account. Results: For all outcomes, the 10-year risk in stage 1 hypertension did not differ significantly from risk in subjects with normal BP: The 10-year risk of cardiovascular events in stage 1 hypertension was 14.1% [95% CI 13.2;15.0] and did not differ significantly from the risk in normal BP at 12.8% [95% CI 11.1;14.5] (p = 0.19). The risk was highest in stage 2 hypertension 19.4% [95% CI 18.9;20.0] and differed significantly from normal BP, elevated BP, and stage 1 hypertension (p < 0.001). The 10-year risk of cardiovascular death was 6.6% [95% CI 5.9;7.4] in stage 1 hypertension and did not differ significantly from the risk in normal BP at 5.7% [95% CI 4.1;7.3] (p = 0.33). Conclusions: Stage 1 hypertension as defined by the ACC/AHA guidelines has the same risk for future cardiovascular events as normal BP. In contrast, the definition of hypertension as suggested by ESC/ESH identifies patients with elevated risk of cardiovascular events.

AB - Aim: The latest guidelines from ACC/AHA define hypertension at systolic blood pressure (SBP) 130-139 mmHg or diastolic blood pressure (DBP) 80-89 mmHg in contrast to guidelines from ESC/ESH defining hypertension at SBP ≥ 140 mmHg or DBP ≥ 90 mmHg. The aim was to determine whether the ACC/AHA definition of hypertension identifies persons at elevated risk for future cardiovascular outcome. Methods: In a Danish prospective cardiovascular study, 19,721 white men and women aged 20-98 years were examined up to five occasions between 1976 and 2015. The population was followed until December 2018. The ACC/AHA definition of the BP levels were applied: Normal: SBP <120 mmHg and DBP <80 mmHg, Elevated: SBP 120-129 mmHg and DBP <80 mmHg, Stage 1: SBP 130-139 mmHg or DBP 80-89 mmHg, Stage 2: SBP ≥140 mmHg or DBP ≥90 mmHg. Absolute 10-year risk was calculated taking repeated examinations, covariates, and competing risk into account. Results: For all outcomes, the 10-year risk in stage 1 hypertension did not differ significantly from risk in subjects with normal BP: The 10-year risk of cardiovascular events in stage 1 hypertension was 14.1% [95% CI 13.2;15.0] and did not differ significantly from the risk in normal BP at 12.8% [95% CI 11.1;14.5] (p = 0.19). The risk was highest in stage 2 hypertension 19.4% [95% CI 18.9;20.0] and differed significantly from normal BP, elevated BP, and stage 1 hypertension (p < 0.001). The 10-year risk of cardiovascular death was 6.6% [95% CI 5.9;7.4] in stage 1 hypertension and did not differ significantly from the risk in normal BP at 5.7% [95% CI 4.1;7.3] (p = 0.33). Conclusions: Stage 1 hypertension as defined by the ACC/AHA guidelines has the same risk for future cardiovascular events as normal BP. In contrast, the definition of hypertension as suggested by ESC/ESH identifies patients with elevated risk of cardiovascular events.

KW - ACC/AHA guidelines

KW - blood pressure thresholds

KW - cardiovascular outcome

KW - hypertension

KW - mortality

U2 - 10.1080/08037051.2024.2380346

DO - 10.1080/08037051.2024.2380346

M3 - Journal article

C2 - 39018201

AN - SCOPUS:85198709985

VL - 33

JO - Blood Pressure

JF - Blood Pressure

SN - 0803-7051

IS - 1

M1 - 2380346

ER -

ID: 399160874